ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer

    NEXT STORY
    ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease
    PREV STORY
    Active Pharmaceutical Ingredient Market Size to Reach USD 261.28 Billion by 2026; Rising Cases of Cancer to Boost Growth, says Fortune Business Insights™
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    author_avatar
    NASDAQ Market News

    Ritter Pharmaceuticals Announces Issuance of New Patents for its Lactose Intolerance Treatment, RP-G28, and Provides an Update on its Path Forward into Phase 3

    LOS ANGELES, May 02, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (“Ritter Pharmaceuticals” ...

    author_avatar
    NASDAQ Market News

    OSE Immunotherapeutics Announces Publication on Anti-IL-7 Receptor Antagonist, OSE-127, in The Journal of Clinical Investigation

    author_avatar
    NASDAQ Market News